There are at least two hurdles confronting the use of the adenovirus ( Ad ) -mediated herpes simplex virus thymidine kinase ( HSVtk ) / ganciclovir ( GCV ) system for the treatment of cancer. One is inefficient Ad vector -mediated gene transfer into tumor cells lacking the primary receptor, i.e., the coxsackievirus and adenovirus receptor ( CAR ). The other is hepatotoxicity due to unwanted vector spread into the liver, even when Ad vectors are injected intratumorally. Herein, we present an attractive strategy for overcoming such limitations based on use of a fiber -modified Ad vector containing an RGD peptide motif in the fiber knob. HSVtk -expressing Ad vectors containing mutant fiber ( AdRGD -tk ) or wild -type fiber ( Ad -tk ) were injected intratumorally into CAR -negative B16 melanoma cells inoculated into mice, after which GCV was injected intraperitoneally for 10 days. AdRGD -tk showed approximately 25 times more antitumor activity than Ad -tk. Histopathological studies suggested that liver damage in mice injected with AdRGD -tk was significantly lower than that in mice injected with Ad -tk. Intratumoral administration of luciferase -expressing Ad vectors containing the mutant fiber ( AdRGD -L2 ) resulted in nearly 40 times more luciferase production in the tumor, but 8 times less production in the liver than the conventional Ad vectors ( Ad -L2 ). These results indicate that combination of fiber -modified vectors and a HSVtk / GCV system is a potentially useful and safe approach for the treatment of tumors lacking CAR expression, and that fiber -modified vectors could be of great utility for gene therapy and gene transfer experiments.
S
uicide gene therapy using herpes simplex virus thymidine kinase (HSVtk ) and ganciclovir ( GCV ) offers a potential treatment strategy for cancer 1 -6 and is undergoing preclinical and clinical trials for a variety of tumors. 7 -11 HSVtk -producing tumor cells become highly sensitive to the antiviral drug GCV, resulting in cell death, because HSVtk transforms GCV into a phosphorylated derivative with potent cytotoxic activity. The ''bystander effect'', an antitumor effect which can be extended to untransduced neighboring tumor cells by the transfer of phosphorylated GCV from HSVtk -expressing cells to adjacent cells through the cellular gap junction, enhances antitumor activity. 12 -14 Several vector systems, including adenovirus (Ad ), retrovirus, herpes simplex virus, and cationic lipid vector systems, have been used for such treatments. Among them, Ad vectors have several advantages over the other vectors; they can easily be grown to high titers and can efficiently transfer foreign genes into both dividing and nondividing cells. 15, 16 However, one of the hurdles confronting Ad -mediated gene transfer is that the gene transfer mediated by Ad vectors into tumor cells lacking the primary receptor, i.e., the coxsackievirus and adenovirus receptor ( CAR ), is inefficient. 17 -19 The use of a fiber-modified vector is an attractive strategy for overcoming this limitation. We and other groups have reported that an Ad vector containing an RGD peptide, which binds with high affinities to integrins ( v3 and v5) on the cell surface, in the HI loop of the fiber knob mediated not only CAR -dependent gene delivery but also CAR -independent, RGD -integrin (v3 and v5)-dependent gene delivery. 20 -23 Ad vectors containing the RGD peptide on their fiber knob mediated 100-1000 times more efficient gene transfer into CAR -deficient cells than the conventional Ad vectors containing wild -type fiber. 22, 24 Because either v3 or v5 integrins are expressed on most types of cells, the exception being certain blood cells, Ad vectors containing RGD peptides on the fiber knob are potentially powerful tools for the treatment of tumors lacking sufficient CAR expression.
Another drawback of Ad vector -mediated HSVtk gene therapy is severe hepatic damage due to unwanted vector spread into remote liver tissues. This can happen even if the Ad vector was injected intratumorally. 25 -30 This problem might also be overcome by the use of a fiber -modified Ad vector. The affinity of such a vector for the tumor cells might be increased and dissemination of the vector from tumor tissues to remote liver tissues might thus be reduced, especially when the tumor cells express relatively small amounts of CAR.
In this study, we used fiber-modified Ad vectors containing an RGD peptide to directly transfer the HSVtk gene into a B16 mouse melanoma that expressed little CAR, but moderate amounts of v integrin, then examined the antitumor activity, dissemination of vectors, and hepatotoxicity in vivo. The results showed that the fiber-modified Ad vectors augmented antitumor effects and reduced dissemination of the vectors ( hepatotoxicity ), as compared with conventional Ad vectors containing wild -type fiber.
Materials and methods

Cells and mice
B16BL6 (mouse melanoma ) cells were cultured with minimum essential medium supplemented with 10% fetal calf serum. C57B16 mice were obtained from Nippon SLC ( Kyoto, Japan ).
Plasmid and virus
Ad vectors were constructed by means of an improved in vitro ligation method described previously. 22, 31, 32 To construct the vector plasmids for the Ad vector expressing HSVtk, pHM3-CMVtk was first constructed by cloning a CMV promoter -driven HSVtk gene, which was derived from pCMTK ( obtained from Riken Gene Bank, Tsukuba, Japan ), into shuttle plasmid pHM3. 31 Then, I -CeuI/PI-SceI -digested pHM3-CMVtk was ligated with I -CeuI/PI-SceI -digested Ad vector plasmid pAdHM4 31 or pAdHM15 -RGD, 22 resulting in pAdHM4 -tk or pAdHM15 -RGD -tk, respectively. To generate the virus, pAdHM4 -tk and pAdHM15-RGD -tk were digested with PacI to release the viral genome and transfected into 293 cells plated in a 60 -mm dish with SuperFect (Qiagen, Valencia, CA ), according to the manufacturer's instructions. Viruses ( Ad -tk and AdRGD -tk ) were prepared as described previously. 33 Adtk contains wild -type fiber, whereas AdRGD -tk contains an RGD peptide motif on the fiber knob. Luciferase -expressing Ad vectors, Ad -L2 and AdRGD -L2, which contain wildtype fiber or the RGD peptide motif on the fiber knob, respectively, were prepared previously. 22 AdRGD -null, which contains no foreign gene expression cassette, was generated by the transfection of pAdHM15 -RGD into 293 cells. Virus particle and infectious (plaque -forming unit, PFU ) titers were determined spectrophotometrically by the method of Maizel et al 34 and by the method of Kanegae et al, 35 respectively. The PFU -to -particle ratio was 1:8 for Ad -L2, 1:23 for AdRGD -L2, 1:7 for Ad -tk, and 1:33 for AdRGD -tk.
Cytotoxicity assay in vitro
B16 cells (1Â10 4 cells) were seeded into a 96-well dish. The following day, they were transduced with Ad -tk or AdRGDtk ( MOI = 6.4, 32, 160, 800, or 4000 ) for 1.5 hours, and then cultured with various concentrations of GCV (Tanabe Pharmaceuticals, Osaka, Japan ). Four days later, the viable cell population was determined by alamar blue assay, which incorporates a fluorometric /colorimetric growth indicator based on detection of metabolic (oxidation -reduction ) activity (Dainippon Pharmaceuticals, Osaka, Japan ). 2 , where a is the larger and b is the shorter diameter ( mm ).
Complete regression was defined as absence of any tumor regrowth for more than 120 days.
Luciferase assay in vivo
To determine transgene expression in the tumor and the liver after injection of conventional Ad vectors and fibermodified Ad vectors, Ad -L2 or AdRGD -L2 (1.4Â10 8 PFU, 50 l) were intratumorally injected; 2 days later, the tumors and liver were recovered and homogenated using the method of Li and Huang. 36 Luciferase productions were determined using a luciferase assay system (PicaGene LT2.0; Toyo Inki, Tokyo, Japan ). Protein content was measured with a Bio -Rad assay kit (Bio-Rad, Hercules, CA ) using bovine serum albumin as a standard.
Toxicity studies
Tumor-bearing mice were intratumorally injected with Adtk or AdRGD -tk (1.4Â10 8 PFU, 50 l) and then treated with GCV. Seven days after injection of Ad -tk or AdRGDtk, the liver was removed and fixed in formalin for 24 hours, then paraffin-embedded, cut in 3-m -thick sections, and stained with hematoxylin and eosin.
Results
Several types of tumor cells are resistant to Ad -mediated gene transduction due to insufficient expression of CAR. 37 -40 This study was undertaken to examine the antitumor effect against CAR -negative melanoma, the dissemination of the vectors, and the hepatic side effects following direct intratumoral delivery of the HSVtk gene mediated by the fiber -modified Ad vector. Mouse B16 melanoma served as the tumor model.
Enhanced gene transfer into cultured B16 cells by fiber -modified Ad vector
Because B16 cells express little CAR, they are resistant to conventional Ad -mediated gene transduction. However, the fiber -modified Ad vector containing the RGD peptide efficiently transferred the foreign gene into B16 cells because B16 cells express integrins v3 and v5, which are target integrins of the RGD peptide motif on the fiber. 24 The Ad vector containing the RGD peptide on the fiber knob infects the cells via not only a CAR -dependent, but also a CAR -independent, RGD -integrin pathway.
Cancer Gene Therapy
Fiber-modified adenovirus-mediated tk gene therapy H Mizuguchi and T Hayakawa First, we constructed HSVtk or luciferase -expressing conventional Ad vectors (Ad -tk, Ad -L2 ) and fibermodified Ad vectors containing the RGD peptide ( AdRGD -tk, AdRGD -L2 ) (Table 1 ) , and their gene transfer potentials into B16 cells were examined by GCV-sensitive cytotoxic assay ( Fig 1 ) . Previously, we demonstrated that AdRGD -L2 mediated luciferase production in B16 cells was more efficient, by 2-3 log orders, than that mediated by Ad -L2. 24 In vitro sensitivities of B16 cells, transduced with AdRGD -tk, to GCV were much higher than those of cells transduced with Ad -tk. The concentrations of GCV required to achieve a cell death rate of 50% ( ED 50 ) of the cell population transduced at MOI =160, 32, or 6.4 of AdRGDtk were 0.79, 2.3, or 6.0 g /mL, respectively. In contrast, ED 50 in the cells transduced at MOI= 4000, 800, or 160 of Ad -tk were 2.5, 5.1, or 25.5 g /mL, respectively. Therefore, taking both MOI and ED 50 into consideration, AdRGD -tk mediated at least 32 -125 times higher cytotoxicity to B16 cells than Ad -tk. [ED 50 in the cells transduced at MOI= 160 of Ad -tk ( 25.5 g/mL ) was 32 times higher than that in the cells transduced at MOI = 160 of AdRGD -tk (0.79 g /mL ). In contrast, Ad -tk at MOI =4000 had an ED 50 similar to that of AdRGD -tk at MOI = 32. In this case, the MOI of Ad -tk was about 125 times higher than that of AdRGD -tk. ]
Enhanced antitumor effect by fiber -modified Ad vector Next, we examined the antitumor effect against B16 cells transplanted into the abdomens of mice (Fig 2) . A single intratumoral injection of Ad -tk or AdRGD -tk was performed, after which GCV was administered intraperitoneally. Administration of Ad -tk, at 7.0Â10 8 PFU, and AdRGD -tk, at 1.4Â10 8 or 2.8Â10 7 PFU, resulted in significant regression of the tumor and prolonged survival of the mice, with three of six mice, three of six mice, and two of six mice, respectively, showing complete tumor regression ( Fig 2 and Table 2 ). On the other hand, administration of AdRGD -null, which does not contain a transgene, at 1.4Â10 8 PFU, had no effect on tumor suppression. Adnull, which contains wild -type fiber and no transgene, at 7.0Â10 8 PFU, also showed no tumor suppressive effect ( data not shown). Ad -tk, at 2.8Â10 7 PFU, and AdRGD -tk, at 5.6Â10 6 PFU, showed only a small suppressive effect on tumors. Because Ad -tk, at 7.0Â10 8 PFU, and AdRGD -tk, at 2.8Â10 7 PFU, produced similar antitumor effects, AdRGDtk exhibited an antitumor effect that was approximately 25 times stronger than that of Ad -tk. This is consistent with the in vitro sensitivities of B16 cells, transduced with Ad -tk or AdRGD -tk, to GCV, as shown in Figure 1 . These results suggest that the combination of fiber-modified Ad vectors containing an RGD peptide and an HSVtk /GCV system can significantly enhance antitumor effects.
Fiber -modified Ad vector efficiently transfers genes into tumors in vivo
To compare the production levels of foreign genes in B16 cells transduced in vivo using a conventional Ad vector versus fiber-modified Ad vectors containing the RGD peptide, Ad -L2 and AdRGD -L2 were administered intratumorally, and 2 days later, luciferase production in the tumor was determined (Fig 3) . A constant dose (1.4Â10 8 PFU ) of each vector was administered because at this dose, AdRGD -tk showed the highest antitumor effect and Ad -tk also showed an (intermediate ) antitumor effect. Luciferase production in hepatic tissue was also measured to examine were intradermally inoculated into the abdomens of C57B16 mice on day 0, and 50 L of Ad-tk or AdRGD -tk was injected intratumorally on day 6. Mice were treated once daily with intraperitoneal injections of GCV for 10 days. Tumor growth was monitored by calculating tumor volume on days 6, 9, 13, 16, and 20. Each point represents the mean ± SE of five to six mice.
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Fiber-modified adenovirus-mediated tk gene therapy H Mizuguchi and T Hayakawa dissemination of the vector into the liver and predict hepatic side effects. Ad vectors leaked from tumors might reach the liver because Ad vectors deliver the foreign gene predominantly to the liver when systemically administered. 41, 42 Fiber-modified Ad vectors containing RGD peptide also deliver the foreign gene predominantly to the liver. 43 AdRGD -L2 resulted in approximately 40 times more intratumoral luciferase production than Ad -L2 (Fig 3 ) . In contrast, hepatic luciferase production mediated by AdRGD -L2 was approximately 1/8 of that mediated by Ad -L2. Luciferase productions in other organs ( lung, heart, spleen, and kidney ) of mice injected with Ad -L2 or AdRGD -L2 were very low (near the background levels, data not shown ) suggesting that the liver is the major site of dissemination following intratumoral administration of an Ad vector. Taken together, these results suggest that fiber-modified vectors containing RGD peptides not only enhance gene transfer into the tumor, but also reduce unwanted vector spread from the tumor into remote liver tissues.
Fiber -modified Ad vector reduces hepatotoxicity
To examine the hepatotoxicity associated with dissemination of the Ad vector into hepatic tissue, histopathological studies Figure 3 Intratumoral and hepatic luciferase productions in mice after intratumoral injection of Ad -L2 or AdRGD -L2. Ad -L2 or AdRGD -L2 ( 1.4Â10 8 PFU ) was injected intratumorally into B16 melanomabearing mice. Two days later, the tumors and liver were isolated, and luciferase production was determined. All data represent the mean ± SD of four mice. Figure 4 Histological analysis of the liver in mice injected intratumorally with Ad -tk or AdRGD -tk. Ad -tk ( A ) or AdRGD -tk ( B ) ( 1.4Â10 8 PFU ) was intratumorally injected into B16 melanomabearing mice. Seven days later, livers were isolated, and histological analyses were performed using hematoxylin and eosin staining. The arrow shows inflammatory infiltration. The congestion of the portal vein is likely due to an artificial, but not significant, lesion.
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8 PFU showed inflammatory cell infiltration ( Fig 4A ) , whereas those from mice given AdRGD -tk at 1.4Â10 8 PFU showed little inflammatory cell infiltration ( Fig 4B ) . Both sections showed minimal hepatocytic necrosis. We also measured serum aspartate amino transferase ( AST ) and alanine amino transferase (ALT ), which are biochemical marker enzymes for hepatotoxicity, 4 and 7 days after gene transfer. AST and ALT levels in mice treated with Ad -tk or AdRGD -tk, at 1.4Â10 8 PFU, were similar to those in untreated mice (data not shown). No body weight change was observed in the mice given Ad -tk or AdRGD -tk (data not shown). Therefore, the mice treated with Ad -tk showed mild hepatotoxicity, whereas those receiving AdRGD -tk showed virtually no hepatotoxicity. These results suggest that combining fiber-modified vectors and an HSVtk /GCV system enhances antitumor effects and reduces hepatic side effects (inflammatory cell infiltration ) in the treatment of tumors lacking CAR expression.
Discussion
This study was undertaken to develop a method of effective cancer gene therapy using a mutant Ad vector containing an RGD peptide in the fiber knob. We hypothesized that modification of fiber increased the binding of the vector to the cells of tumors expressing relatively small amounts of CAR, thereby resulting in not only a higher antitumor effect, but also decreased vector dissemination.
The higher transduction efficiency achieved by the fibermodified Ad vector would be of substantial benefit for cancer gene therapy. RGD peptide motifs that have high affinity for v3 and v5 integrins would be appropriate for modifying the fiber for cancer gene therapy. This is because most cells, the exception being most (certain ) blood cells such as hematopoietic progenitor cells, express sufficient levels of v3 and/ or v5 integrins. The transduction efficiency into B16 melanoma cells, which lack CAR expression, was dramatically augmented both in vitro and in vivo by fiber-modified Ad vectors containing RGD peptides, leading to increased cytotoxic activity in vitro and an increased antitumor effect against B16 melanoma cells in vivo via delivery of the HSVtk gene ( Figs 1 -3 ) . Similar antitumor effects were obtained with the conventional Ad vector, at 7.0Â10 8 PFU, and the fiber-modified Ad vector, at 2.8Â10 7 PFU, suggesting that fiber-modified Ad vectors augment antitumor effects approximately 25 -fold as compared with the conventional Ad vector. Shinoura et al reported that transduction of HSVtk -expressing fibermutant Ad vectors containing a stretch of 20 lysine residues at the C -terminus of the fiber, which has affinity to heparan sulfate, augments the cytopathic effect in glioma cells. 44 However, they showed only in vitro results.
Fiber-modified Ad vectors containing RGD peptides showed not only higher antitumor effects, but also reduced hepatic vector dissemination, which should result in reduced hepatic toxicity. This could be explained by the higher transduction efficiency of fiber-modified Ad vectors into B16 cells, which would reduce unwanted vector spread from the tumor tissues. When the same amounts of Ad -L2 and AdRGD -L2 ( 1.4Â10 8 PFU ) were injected into tumors, AdRGD -L2 resulted in nearly 40 times higher intratumoral luciferase expression, and approximately 8 times lower luciferase expression in the liver, than Ad -L2 ( Fig 3) . The enhanced transduction efficiency by fiber-modified Ad vectors reduces the total dose of Ad vector required to obtain antitumor effects similar to those of conventional Ad vectors. Thus, if fiber-modified Ad vectors were administered at a dose that showed a transduction efficiency in tumors (antitumor effect ) similar to that of conventional Ad vectors, luciferase production in the liver by fiber-modified Ad vectors would be much lower than with the conventional Ad vector.
Due to decreased gene transfer into the liver, hepatotoxicity, e.g., inflammatory cell infiltration, was also reduced in mice that received AdRGD -tk as compared with those that received Ad -tk (Fig 4) . Although several studies have reported that Ad -mediated HSVtk /GCV systems mediate the elevation of serum AST and ALT, 28 -30,45 which are clinically relevant markers of liver damage, neither AST nor ALT levels were increased in mice treated with Ad -tk and AdRGD -tk in the present study (data not shown ). This might be at least partially attributable to the lower dose of Ad vectors used in our study ( PFU showed marked elevations of these markers. Other studies have shown that lower doses of Ad vectors expressing HSVtk did not increase serum AST and ALT levels, whereas high doses did. 30, 45 These reports support our findings. Taking into consideration the AdRGD -L2 -mediated decrease in hepatic luciferase production, as compared with Ad -L2, the fiber -modified Ad vector containing the RGD peptide should be associated with lower hepatotoxicity.
Although Ad vectors containing RGD peptide in the fiber knob decreased transgene expression in the liver, some expression was still observed ( Fig 3) . Several reports have demonstrated that use of a tumor-specific promoter in the Ad vector prevents the expression of HSVtk in the normal liver, thereby reducing hepatotoxicity. 27, 45 Inclusion of a tumor-specific promoter in the fiber-modified Ad vector may further increase the therapeutic effect and reduce unwanted transgene expression and side effects.
Systemically administered Ad vectors, including the Ad vector containing RGD peptide on the fiber knob, delivered more than 90% of the input virus to the liver. 41 -43 This property is probably due to both high levels of CAR and v integrin expression in the liver and large endothelial pores to gain easy access to the liver. 46, 47 The vector that no longer infects the cells via CAR and v integrin, but rather infects cells via tumor-specific molecules ( proteins ), would more greatly reduce the dissemination from the tumor. We are currently developing such a truly targeted Ad vector.
In summary, the combination of a fiber-modified Ad vector and an HSVtk /GCV system enhanced antitumor effects and reduced hepatic side effects in this study. This
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